131 related articles for article (PubMed ID: 19076338)
1. An introduction to chemokines and their roles in transfusion medicine.
Davenport RD
Vox Sang; 2009 Apr; 96(3):183-98. PubMed ID: 19076338
[TBL] [Abstract][Full Text] [Related]
2. Chemokines and chemokine receptors: their manifold roles in homeostasis and disease.
Le Y; Zhou Y; Iribarren P; Wang J
Cell Mol Immunol; 2004 Apr; 1(2):95-104. PubMed ID: 16212895
[TBL] [Abstract][Full Text] [Related]
3. The chemokine system in allogeneic stem-cell transplantation: a possible therapeutic target?
Melve GK; Ersvssr E; Kittang AO; Bruserud O
Expert Rev Hematol; 2011 Oct; 4(5):563-76. PubMed ID: 21939423
[TBL] [Abstract][Full Text] [Related]
4. Virus-encoded chemokine receptors--putative novel antiviral drug targets.
Rosenkilde MM
Neuropharmacology; 2005 Jan; 48(1):1-13. PubMed ID: 15617722
[TBL] [Abstract][Full Text] [Related]
5. Chemokine regulation of normal and pathologic immune responses.
Christopherson K; Hromas R
Stem Cells; 2001; 19(5):388-96. PubMed ID: 11553847
[TBL] [Abstract][Full Text] [Related]
6. Location, movement and survival: the role of chemokines in haematopoiesis and malignancy.
Laurence AD
Br J Haematol; 2006 Feb; 132(3):255-67. PubMed ID: 16409290
[TBL] [Abstract][Full Text] [Related]
7. Transfusion-associated iron overload as an adverse risk factor for transplantation outcome in patients undergoing reduced-intensity stem cell transplantation for myeloid malignancies.
Kim YR; Kim JS; Cheong JW; Song JW; Min YH
Acta Haematol; 2008; 120(3):182-9. PubMed ID: 19129689
[TBL] [Abstract][Full Text] [Related]
8. Immune reconstitution following myeloablative allogeneic hematopoietic stem cell transplantation: the impact of expanding CD28negative CD8+ T cells on relapse.
Yakoub-Agha I; Saule P; Magro L; Cracco P; Duhamel A; Coiteux V; Bruno B; Dufossé F; Jouet JP; Dessaint JP; Labalette M
Biol Blood Marrow Transplant; 2009 Apr; 15(4):496-504. PubMed ID: 19285638
[TBL] [Abstract][Full Text] [Related]
9. Tuning inflammation and immunity by chemokine sequestration: decoys and more.
Mantovani A; Bonecchi R; Locati M
Nat Rev Immunol; 2006 Dec; 6(12):907-18. PubMed ID: 17124512
[TBL] [Abstract][Full Text] [Related]
10. Chemokines in atherosclerosis: an update.
Zernecke A; Shagdarsuren E; Weber C
Arterioscler Thromb Vasc Biol; 2008 Nov; 28(11):1897-908. PubMed ID: 18566299
[TBL] [Abstract][Full Text] [Related]
11. From leukocyte reduction to leukocyte transfusion: the immunological effects of transfused leukocytes.
Lee JH; Klein HG
Baillieres Best Pract Res Clin Haematol; 2000 Dec; 13(4):585-600. PubMed ID: 11102278
[TBL] [Abstract][Full Text] [Related]
12. Activating killer immunoglobulin-like receptor incompatibilities enhance graft-versus-host disease and affect survival after allogeneic hematopoietic stem cell transplantation.
Giebel S; Nowak I; Dziaczkowska J; Czerw T; Wojnar J; Krawczyk-Kulis M; Holowiecki J; Holowiecka-Goral A; Markiewicz M; Kopera M; Karolczyk A; Kyrcz-Krzemien S; Kusnierczyk P
Eur J Haematol; 2009 Oct; 83(4):343-56. PubMed ID: 19500138
[TBL] [Abstract][Full Text] [Related]
13. Viral exploitation and subversion of the immune system through chemokine mimicry.
Murphy PM
Nat Immunol; 2001 Feb; 2(2):116-22. PubMed ID: 11175803
[TBL] [Abstract][Full Text] [Related]
14. [Immunological effects of erythrocyte and leukocyte transfusion. Work Group Blood Group Serology of the Medical Advisory Commission of the College for Blood Transfusion of the Netherlands Red Cross].
Brand A; van Rhenen DJ
Ned Tijdschr Geneeskd; 1997 Jan; 141(3):136-40. PubMed ID: 9053759
[TBL] [Abstract][Full Text] [Related]
15. Role of antithymocyte globulin and granulocyte-colony stimulating factor-mobilized bone marrow in allogeneic transplantation for patients with hematologic malignancies.
Chen XH; Zhang C; Zhang X; Gao L; Gao L; Kong PY; Peng XG; Qi DG; Sun AH; Zeng DF; Liu H; Gong Y; Wang QY
Biol Blood Marrow Transplant; 2009 Feb; 15(2):266-73. PubMed ID: 19167687
[TBL] [Abstract][Full Text] [Related]
16. Proteolytic processing of chemokines: implications in physiological and pathological conditions.
Wolf M; Albrecht S; Märki C
Int J Biochem Cell Biol; 2008; 40(6-7):1185-98. PubMed ID: 18243768
[TBL] [Abstract][Full Text] [Related]
17. Phase I study of high-stringency CD8 depletion of donor leukocyte infusions after allogeneic hematopoietic stem cell transplantation.
Orti G; Lowdell M; Fielding A; Samuel E; Pang K; Kottaridis P; Morris E; Thomson K; Peggs K; Mackinnon S; Chakraverty R
Transplantation; 2009 Dec; 88(11):1312-8. PubMed ID: 19996931
[TBL] [Abstract][Full Text] [Related]
18. [Laboratory medicine for blood transfusion and transplantation medicine].
Saigo K; Hashimoto M; Sugimoto T; Takenokuchi M; Imoto S; Kumagai S
Rinsho Byori; 2008 Mar; 56(3):203-10. PubMed ID: 18411804
[TBL] [Abstract][Full Text] [Related]
19. Interferon gamma 13-CA-repeat homozygous genotype and a low proportion of CD4(+) lymphocytes are independent risk factors for cytomegalovirus reactivation with a high number of copies in hematopoietic stem cell transplantation recipients.
Jaskula E; Dlubek D; Duda D; Bogunia-Kubik K; Mlynarczewska A; Lange A
Biol Blood Marrow Transplant; 2009 Oct; 15(10):1296-305. PubMed ID: 19747638
[TBL] [Abstract][Full Text] [Related]
20. Nonmyeloablative and reduced-intensity conditioning for allogeneic hematopoietic stem cell transplantation: a clinical review.
Pollack SM; O'Connor TP; Hashash J; Tabbara IA
Am J Clin Oncol; 2009 Dec; 32(6):618-28. PubMed ID: 19593085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
